The specimen of choice that enables the collection of small blood volumes from neonatal or critically ill patients is a capillary blood specimen. This specimen type has gained favour with many ...
AUSTIN, TX / ACCESS Newswire / March 31, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced a ...
Babson and BD are advancing development of the blood testing ecosystem, which includes BD’s capillary-collection technology and Babson’s proprietary automated sample-handling and analytical ...
AUSTIN, Texas and FRANKLIN LAKES, N.J., May 11, 2022 /PRNewswire/ -- Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading ...
Capillary blood tests measure p-tau217, GFAP, and NfL without strict temperature controls or immediate centrifugation. Primary care physicians currently have a diagnostic accuracy of ~61% for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results